Fcγ-receptor IIA genotype and invasive pneumococcal infection

Clinical Immunology

Volumn 118, Issue 1, 2006, Pages 20-23

  Moens, Leen ^a   Van Hoeyveld, Erna ^a   Verhaegen, Jan ^a   De Boeck, Kris ^a   Peetermans, Willy E ^a   Bossuyt, Xavier ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Fc RIIA polymorphism; Invasive pneumococcal infection; Streptococcus pneumoniae

Indexed keywords

FC RECEPTOR; ISOPROTEIN; FC GAMMA RECEPTOR IIA; LEUKOCYTE ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CAUCASIAN; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; PATHOGENESIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; STREPTOCOCCUS INFECTION; AGE; CLASSIFICATION; DEMOGRAPHY; GENE FREQUENCY; GENETICS; ISOLATION AND PURIFICATION; MIDDLE AGED; PRESCHOOL CHILD; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIGENS, CD; CHILD; CHILD, PRESCHOOL; DEMOGRAPHY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INFANT; MALE; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; RECEPTORS, IGG; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 29444446788     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2005.08.002     Document Type: Article

References (28)

1. D.M. Musher Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity, and treatment Clin. Inf. Dis. 14 1992 801 809
2. N.M. van Sorge, W.-L. van der Pol, and J.G.J. van de Winkel FcγR polymorphisms: implications for function, disease susceptibility and immunotherapy Tissue Antigens 61 2003 189 202
3. L.A.M. Sanders, R.G. Feldman, M.M. Voorhorst-Ogink, M. de Haas, G.T. Rijkers, and P.J.A. Capel Human immunoglobulin G (IgG) Fc receptor IIA (CD32) polymorphism and IgG2-mediated bacterial phagocytosis by neutrophils Infect. Immun. 63 1995 73 81
4. A.M. Yee, S.C. Ng, R.E. Sobel, and J.E. Salmon FcγRIIA polymorphism as a risk factor for invasive pneumococcal infections in systemic lupus erythematosus Arthritis Rheum. 40 1997 1180 1182
5. A.M. Yee, H.M. Phan, R. Zuniga, J.E. Salmon, and D.M. Musher Association between FcγRIIA allotype and bacteremic pneumococcal pneumonia Clin. Infect. Dis. 30 2000 25 28
6. F.F. Yuan, M. Wong, N. Pererva, J. Keating, A.R. Davis, and J.A. Bryant FcγRIIA polymorphisms in Streptococcus pneumoniae infection Immunol. Cell Biol. 81 2003 129 195
7. E. Van Hoeyveld, F. Houtmeyers, C. Massonet, L. Moens, M. Van Ranst, and N. Blanckaert Detection of single nucleotide polymorphisms in the mannose-binding lectin gene using minor groove binder-DNA probes J. Immunol. Methods 287 2004 227 230
8. L.A.M. Sanders, J.G.J. van de Winkel, G.T. Rijkers, M.M. Voorhorst-Ogink, M. De Haas, and P.J.A. Capel Fcγ receptor IIa (CD32) heterogeneity in patients with recurrent bacterial respiratory tract infections J. Infect. Dis. 170 1994 854 861
9. A.E. Platonov, G.A. Shipulin, I.V. Vershinina, J. Dankert, J.G.J. van de Winkel, and E.J. Kuiper Association of human FcγRIIA (CD32) polymorphism with susceptibility to and severity of meningococcal disease Clin. Infect. Dis. 27 1998 746 750
10. P. Domingo, E. Muñiz-Diaz, M.A. Baraldès, M. Arilla, N. Barquet, and R. Pericas Associations between Fc gamma receptor IIA polymorphisms and the risk and prognosis of meningococcal disease Am. J. Med. 112 2002 19 25
11. I. Smith, C. Vedeler, and A. Hastensen FcγRIIa and FcγRIIIb polymorphisms were not associated with meningococcal disease in Western Norway Epidemiol. Infect. 130 2003 193 199
12. R. Carsetti, M.M. Rosado, S. Donnanno, V. Guazzi, A. Soresina, A. Meini, A. Plebani, F. Aiuti, and I. Quinti The loss of IgM memory B cells correlates with clinical disease in common variable immunodeficiency J. Allergy Clin. Immunol. 115 2005 412 417
13. J.S. Brown, T. Hussell, S.M. Gilliland, D.W. Holden, J.C. Paton, M.R. Ehrenstein, M.J. Walport, and M. Botto The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice Proc. Natl. Acad. Sci. 99 26 2002 16969 16974
14. C.A. Janeway, and R. Medzhitov Innate immune recognition Annu. Rev. Immunol. 20 2002 197 216
15. S. Roy, K. Knox, S. Segal, D. Griffiths, C.E. Moore, K.I. Welsh, A. Smarason, N.P. Day, W.L. McPheat, D.W. Crook, A.V.S. Hill and the Oxford Pneumococcal Surveillance Group MBL genotype and risk of invasive pneumococcal disease: a case-control study Lancet 359 2002 1569 1573
16. G. Kronborg, N. Weis, H.O. Madsen, S.S. Pedersen, C. Wejse, H. Nielsen, P. Skinhøj, and P. Garred Variant Mannose-binding lectin alleles are not associated with susceptibility to or outcome of invasive pneumococcal infection in randomly included patients J. Infect. Dis. 185 2002 1517 1520
17. G. Kronborg, and P. Garred Mannose-binding lectin genotype as risk factor for invasive pneumococcal infection Lancet 360 2002 1176
18. E. Lorenz, J.P. Mira, K.L. Cornish, N.C. Arbour, and D.A. Schwartz A novel polymorphism in the Toll-like receptor 2 gene and its potential association with Staphylococcal infection Infect. Immun. 68 11 2000 6398 6401
19. D.N. Cook, D.S. Pisetsky, and D.A. Schwartz Toll-like receptors in the pathogenesis of human disease Nat. Immunol. 5 10 2004 975 979
20. A. Yoshimura, E. Lien, R.R. Ingalls, E. Toumanen, R. Dziarski, and D. Golenbock Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2 J. Immunol. 163 1999 1 5
21. U. Koedel, B. Angele, T. Rupprecht, H. Wagner, A. Roggenkamp, and H. Phister Toll-like receptor 2 participates in mediation of immune response in experimental pneumococcal meningitis J. Immunol. 170 2003 438 444
22. H. Echchannaoui, K. Frei, C. Schnell, S.L. Leib, W. Zimmerli, and R. Landmann Toll-like receptor 2-deficient mice are highly susceptible to Streptococcus pneumoniae meningitis because of reduced bacterial clearing and enhanced inflammation J. Infect. Dis. 186 2002 798 806
23. A.Q. Khan, Q. Chen, Z.-Q. Wu, J. Paton, and C.M. Snapper Both innate immunity and type 1 humoral immunity to Streptococcus pneumoniae are mediated by MyD88 but differ in their relative levels of dependence on Toll-like receptor 2 Infect. Immun. 73 1 2005 298 307
24. S. Knapp, C.W. Wieland, C. van't Veer, O. Takeuchi, S. Akira, and S. Florquin Toll-like receptor 2 plays a role in the early inflammatory response to murine pneumococcal pneumonia but does not contribute to antibacterial defense J. Immunol. 172 2004 3132 3138
25. J. Branger, S. Knapp, S. Weijer, J.C. Leemans, J.M. Pater, and P. Speelman Role of Toll-like receptor 4 in Gram-positive and Gram-negative pneumonia in mice Infect. Immun. 72 2 2004 788 794
26. R. Malley, P. Henneke, S.C. Morse, M.J. Cieslewicz, M. Lipsitch, and C.M. Thompson Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection Proc. Natl. Acad. Sci. 100 4 2003 1966 1971
27. W.J. Schröder, and R.R. Schumann Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease Lancet, Infect. Dis. 5 2005 156 164
28. W.R. Usinger, and A.H. Lucas Avidity as a determinant of the protective efficacy of human antibodies to pneumococcal capsular polysaccharides Infect. Immun. 67 5 1999 2366 2370